RNASEL plays a significant role in viral clearance and it has been suggested that variation in RNASEL may alter risk of viral-associated cancers, such as head and neck squamous cell carcinoma and cervical cancer, as well as non-viral cancers such as breast cancer [45], [46]. Here, RNASEL is linked to cervical carcinoma.